Related Experiment Video
Updated: Mar 25, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Portraits of TET-mediated DNA hydroxymethylation in cancer
Jana Jeschke1, Evelyne Collignon1, François Fuks1
1Laboratory of Cancer Epigenetics, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium.
Abstract:
The discovery of TET-mediated DNA hydroxymethylation as a mechanism of DNA demethylation, along with the observation of disrupted hydroxymethylation patterns in cancer, sparked high hopes of better understanding malignant processes. In this review, we discuss a plethora of recent studies that have shed light on the mechanisms and biological consequences of DNA hydroxymethylation pattern changes in various cancers. A picture is taking shape, in which TET proteins appear as both promoters and suppressors of cancer. Their impairment at multiple levels creates abnormal 5hmC landscapes that affect, often in concert with key cancer pathways, a wider range of biological processes than initially proposed. As the picture gains in scope and precision, the prospect of 5hmC-pattern-targeting cancer therapies shimmers in the distance.
Insights
DNA hydroxymethylation, regulated by TET proteins, plays a dual role in cancer. Altered 5-hydroxymethylcytosine (5hmC) patterns impact cancer pathways, offering potential for new therapies.
Area of Science:
- Epigenetics and Cancer Biology
Background:
- TET-mediated DNA hydroxymethylation is a key DNA demethylation mechanism.
- Disrupted 5-hydroxymethylcytosine (5hmC) patterns are observed in various cancers.
- This has generated significant interest in understanding its role in malignancy.
Purpose of the Study:
- To review recent studies on the mechanisms and biological consequences of DNA hydroxymethylation pattern changes in cancer.
- To elucidate the complex roles of TET proteins in cancer development.
- To explore the implications of altered 5hmC landscapes in oncogenic pathways.
Main Methods:
- Comprehensive review of recent scientific literature.
- Analysis of studies investigating TET protein function and 5hmC patterns in cancer.
- Synthesis of findings on the biological impact of altered hydroxymethylation.
Main Results:
- TET proteins function as both promoters and suppressors of cancer.
- Impairment of TET proteins leads to abnormal 5hmC landscapes.
- These alterations affect a broad range of biological processes, often interacting with key cancer pathways.
Conclusions:
- Altered DNA hydroxymethylation patterns are integral to cancer biology.
- The dual role of TET proteins highlights the complexity of epigenetic regulation in malignancy.
- Targeting 5hmC patterns presents a promising future direction for cancer therapies.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

